Global Ivermectin Medication Market Insights, Forecast to 2028

Ivermectin is a medication used to treat many types of parasite infestations. It can be taken by mouth or applied to the skin for external infestations. This report is focus on Ivermectin Finished Dosage.
Market Analysis and Insights: Global Ivermectin Medication Market
Due to the COVID-19 pandemic, the global Ivermectin Medication market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tablet accounting for % of the Ivermectin Medication global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oral segment is altered to an % CAGR throughout this forecast period.
China Ivermectin Medication market size is valued at US$ million in 2021, while the US and Europe Ivermectin Medication are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ivermectin Medication landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Ivermectin Medication include MERCK, Delta Pharma, Galderma, Arbor Pharmaceuticals, Boehringer Ingelheim and Edenbridge Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ivermectin Medication Scope and Segment
Ivermectin Medication market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ivermectin Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Injection
Lotion
Cream
Segment by Application
Oral
External Use
By Company
MERCK
Delta Pharma
Galderma
Arbor Pharmaceuticals
Boehringer Ingelheim
Edenbridge Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE